Alu-mediated Xq24 deletion encompassing CUL4B, LAMP2, ATP1B4, TMEM255A, and ZBTB33 genes causes Danon disease in a female patient.


Journal

American journal of medical genetics. Part A
ISSN: 1552-4833
Titre abrégé: Am J Med Genet A
Pays: United States
ID NLM: 101235741

Informations de publication

Date de publication:
01 2020
Historique:
received: 02 08 2019
revised: 08 10 2019
accepted: 04 11 2019
pubmed: 16 11 2019
medline: 29 12 2020
entrez: 16 11 2019
Statut: ppublish

Résumé

Cullin 4B (CUL4B), lysosomal-associated membrane protein Type 2 (LAMP2), ATP1B4, TMEM255A, and ZBTB33 are neighboring genes on Xq24. Mutations in CUL4B result in Cabezas syndrome (CS). Male CS patients present with dysmorphic, neuropsychiatric, genitourinary, and endocrine abnormalities. Heterozygous CS females are clinically asymptomatic. LAMP2 mutations cause Danon disease (DD). Cardiomyopathy is a dominant feature of DD present in both males and heterozygous females. No monogenic phenotypes have been associated with mutations in ATP1B4, TMEM255A, and ZBTB33 genes. To facilitate diagnostics and counseling in CS and DD families, we present a female DD patient with a de novo Alu-mediated Xq24 rearrangement causing a deletion encompassing CUL4B, LAMP2, and also the other three neighboring genes. Typical to females heterozygous for CUL4B mutations, the patient was CS asymptomatic, however, presented with extremely skewed X-chromosome inactivation (XCI) ratios in peripheral white blood cells. As a result of the likely selection against CUL4B deficient clones, only minimal populations (~3%) of LAMP2 deficient leukocytes were identified by flow cytometry. On the contrary, myocardial LAMP2 protein expression suggested random XCI. We demonstrate that contiguous CUL4B and LAMP2 loss-of-function copy number variations occur and speculate that male patients carrying similar defects could present with features of both CS and DD.

Identifiants

pubmed: 31729179
doi: 10.1002/ajmg.a.61416
doi:

Substances chimiques

ATP1B4 protein, human 0
CUL4B protein, human 0
Cullin Proteins 0
LAMP2 protein, human 0
Lysosomal-Associated Membrane Protein 2 0
Transcription Factors 0
Sodium-Potassium-Exchanging ATPase EC 7.2.2.13

Types de publication

Case Reports Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

219-223

Subventions

Organisme : Magistrát hlavního města Prahy, Česká Republika
ID : CZ.2.16/3.1.00/24505
Pays : International
Organisme : Ministerstvo Školství, Mládeže a Tělovýchovy České Republiky
ID : NCMG LM2015091
Pays : International
Organisme : Ministerstvo Školství, Mládeže a Tělovýchovy České Republiky
ID : LO1604
Pays : International
Organisme : Ministerstvo Zdravotnictví České Republiky
ID : AZV-MZ ČR 15-27682A
Pays : International
Organisme : Ministerstvo Zdravotnictví České Republiky
ID : NV19-08-00122
Pays : International
Organisme : Ministerstvo Zdravotnictví České Republiky
ID : RVO-VFN 64165/2012
Pays : International
Organisme : Ministerstvo Zdravotnictví České Republiky
ID : VZ IKEM (00023001)
Pays : International
Organisme : Univerzita Karlova v Praze
ID : PROGRESS Q25
Pays : International
Organisme : Univerzita Karlova v Praze
ID : PROGRESS Q26
Pays : International
Organisme : Univerzita Karlova v Praze
ID : SVV UK 260367/2017
Pays : International
Organisme : Univerzita Karlova v Praze
ID : UNCE 204064
Pays : International

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Références

Brambatti, M., Caspi, O., Maolo, A., Koshi, E., Greenberg, B., Taylor, M. R. G., & Adler, E. D. (2019). Danon disease: Gender differences in presentation and outcomes. International Journal of Cardiology, 286, 92-98.
Isidor, B., Pichon, O., Baron, S., David, A., & Le Caignec, C. (2010). Deletion of the CUL4B gene in a boy with mental retardation, minor facial anomalies, short stature, hypogonadism, and ataxia. American Journal of Medical Genetics, Part A, 152A(1), 175-180.
Jiang, B., Zhao, W., Yuan, J., Qian, Y., Sun, W., Zou, Y., … Gong, Y. (2012). Lack of Cul4b, an E3 ubiquitin ligase component, leads to embryonic lethality and abnormal placental development. PLoS One, 7(5), e37070.
Majer, F., Pelak, O., Kalina, T., Vlaskova, H., Dvorakova, L., Honzik, T., … Sikora, J. (2014). Mosaic tissue distribution of the tandem duplication of LAMP2 exons 4 and 5 demonstrates the limits of Danon disease cellular and molecular diagnostics. Journal of Inherited Metabolic Disease, 37(1), 117-124.
Majer, F., Piherova, L., Reboun, M., Stara, V., Pelak, O., Norambuena, P., … Sikora, J. (2018). LAMP2 exon-copy number variations in Danon disease heterozygote female probands: Infrequent or underdetected? American Journal of Medical Genetics, Part A, 176(11), 2430-2434.
Majer, F., Vlaskova, H., Krol, L., Kalina, T., Kubanek, M., Stolnaya, L., … Sikora, J. (2012). Danon disease: A focus on processing of the novel LAMP2 mutation and comments on the beneficial use of peripheral white blood cells in the diagnosis of LAMP2 deficiency. Gene, 498(2), 183-195.
Ravn, K., Lindquist, S. G., Nielsen, K., Dahm, T. L., & Tumer, Z. (2012). Deletion of CUL4B leads to concordant phenotype in a monozygotic twin pair. Clinical Genetics, 82(3), 292-294.
Schackmann, R. C., Tenhagen, M., van de Ven, R. A., & Derksen, P. W. (2013). p120-catenin in cancer - Mechanisms, models and opportunities for intervention. Journal of Cell Science, 126(Pt 16), 3515-3525.
Sikora, J., Majer, F., & Kalina, T. (2015). LAMP2 flow cytometry in peripheral white blood cells is an established method that facilitates identification of heterozygous Danon disease female patients and mosaic mutation carriers. Journal of Cardiology, 66(1), 88-89.
Tarpey, P. S., Raymond, F. L., O'Meara, S., Edkins, S., Teague, J., Butler, A., … Partington, M. (2007). Mutations in CUL4B, which encodes a ubiquitin E3 ligase subunit, cause an X-linked mental retardation syndrome associated with aggressive outbursts, seizures, relative macrocephaly, central obesity, hypogonadism, pes cavus, and tremor. American Journal of Human Genetics, 80(2), 345-352.
UniProtKB. https://www.uniprot.org/uniprot/Q5JRV8.
Verma, R., & Babu, A. (1995). Human chromosomes: Principles & techniques (2nd ed.). New York: McGraw-Hill, Inc.
Zhao, H., Pestov, N. B., Korneenko, T. V., Shakhparonov, M. I., & Modyanov, N. N. (2004). Accumulation of beta (m), a structural member of X,K-ATPase beta-subunit family, in nuclear envelopes of perinatal myocytes. American Journal of Physiology Cell Physiology, 286(4), C757-C767.
Zou, Y., Liu, Q., Chen, B., Zhang, X., Guo, C., Zhou, H., … Gong, Y. (2007). Mutation in CUL4B, which encodes a member of cullin-RING ubiquitin ligase complex, causes X-linked mental retardation. American Journal of Human Genetics, 80(3), 561-566.

Auteurs

Filip Majer (F)

Research Unit for Rare Diseases, Department of Pediatrics and Adolescent Medicine, 1st Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.

Bohdan Kousal (B)

Research Unit for Rare Diseases, Department of Pediatrics and Adolescent Medicine, 1st Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
Department of Ophthalmology, 1st Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.

Petr Dusek (P)

Department of Neurology and Center of Clinical Neuroscience, 1st Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
Department of Radiology, 1st Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.

Lenka Piherova (L)

Research Unit for Rare Diseases, Department of Pediatrics and Adolescent Medicine, 1st Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.

Martin Reboun (M)

Research Unit for Rare Diseases, Department of Pediatrics and Adolescent Medicine, 1st Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.

Romana Mihalova (R)

Institute of Biology and Medical Genetics, 1st Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.

Jiri Gurka (J)

Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.

Alice Krebsova (A)

Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.

Hana Vlaskova (H)

Research Unit for Rare Diseases, Department of Pediatrics and Adolescent Medicine, 1st Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.

Lenka Dvorakova (L)

Research Unit for Rare Diseases, Department of Pediatrics and Adolescent Medicine, 1st Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.

Jana Krihova (J)

Department of Psychology, Thomayer Hospital, Prague, Czech Republic.

Petra Liskova (P)

Research Unit for Rare Diseases, Department of Pediatrics and Adolescent Medicine, 1st Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
Department of Ophthalmology, 1st Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.

Stanislav Kmoch (S)

Research Unit for Rare Diseases, Department of Pediatrics and Adolescent Medicine, 1st Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.

Tomas Kalina (T)

Department of Paediatric Haematology and Oncology, Childhood Leukaemia Investigation Prague, 2nd Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic.

Milos Kubanek (M)

Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.

Jakub Sikora (J)

Research Unit for Rare Diseases, Department of Pediatrics and Adolescent Medicine, 1st Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
Institute of Pathology, 1st Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH